Obesity Featured Articles

  1. Building Trust: Overcoming Barriers To Clinical Trial Diversity 6/6/2025

    Examine the critical issue of underrepresentation of minority groups in clinical trials, highlighting the systemic barriers and historical mistrust that contribute to this disparity.

  2. Decentralized Solutions: Expanding Clinical Trial Access 6/6/2025

    The clinical research landscape is increasingly adopting decentralized clinical trials (DCTs) and hybrid designs to enhance patient accessibility, inclusivity, and diversity.

  3. When CRO Selection Went Sideways, Ashvattha Therapeutics Did This To Recover 6/6/2025

    Ashvattha Therapeutics CEO Jeff Cleland, Ph.D. shares a near-catastrophic CRO experience and explains how his team rebounded just in time.

  4. ICH E6(R3) And A Risk-Based Approach As A Competitive Advantage  6/5/2025

    ICH E6 (R3) advocates for a streamlined, risk-informed trial design that enhances quality and participant experience, paving the way for more efficient and successful clinical research outcomes.

  5. What Happened At ASCO 2025? 6/5/2025

    ASCO 2025 underscored both the momentum in oncology innovation and the critical need to protect the infrastructure that enables it—ensuring that tomorrow’s breakthroughs remain within reach for all patients.

  6. Evolving Neurology And Neuroinflammation Therapies And Trials In 2025 6/5/2025

    Could 2025 be the year that advancements in brain health and increased funding for innovative therapies make a difference for neuroinflammation therapies and trials? Immunic CEO Daniel Vitt, Ph.D., discusses.

  7. Ensuring Compliance When Using Wearables In Clinical Trials 6/4/2025

    As wearable technology takes on a central role in clinical research, explore how its benefits can be maximized while navigating the increasing complexity of regulatory compliance.

  8. AI-Powered Breakthroughs In CNS And Pain Trials 6/4/2025

    Discover how AI-powered tools like EEG are revolutionizing neurological and pain clinical trials by replacing subjectivity with precision and drastically accelerating the path to approval.

  9. Everything To Know About Long-Term Data Collection For Cell And Gene Therapy Trials In The EU 6/4/2025

    Discover how to secure uninterrupted access to long-term trial data for CAR-T therapies by participating in the European Society for Blood and Marrow Transplantation (EBMT) CAR-T Data Collection Initiative. 

  10. Nurturing Clinical Site Relationships Drives Trial Success 6/3/2025

    Whether a clinical trial is studying rare disease therapies or large-volume vaccines, three Ps define the approach to site feasibility: patients, product, and procedures. Advanced technological and methodological tools can assist sponsors, CROs, and sites in identifying fruitful collaborations, but person-to-person discussion and communication must drive those collaborations.